一種自我錨定的縫合線被設(shè)計(jì)用于皮膚組織傷口的縫合。這種縫合線已經(jīng)得到了美國(guó)食品藥品管理局的批準(zhǔn)。

Quill醫(yī)學(xué)公司以該公司獲得的新型縫合線工藝為基礎(chǔ)，研制出了一系列組織修復(fù)器器具，聚對(duì)二氧環(huán)已酮縫合線是這個(gè)系列中的第一種。四十多位產(chǎn)科醫(yī)生或者婦科醫(yī)生參加了一項(xiàng)臨床試驗(yàn)，評(píng)估這種新型縫合線在縫合剖腹產(chǎn)切口的能力，該研究涉及195例患者。醫(yī)生發(fā)現(xiàn)使用新型縫合線比傳統(tǒng)縫合線縫合切口更加方便快捷。

Quill醫(yī)學(xué)公司執(zhí)行總裁和總監(jiān)Matthew Megaro指出：“全球外科醫(yī)生每年使用數(shù)千萬(wàn)縫合線來(lái)閉合傷口與修補(bǔ)組織，所有這些縫合線都必須打結(jié)。而Quill自我錨定縫合線則無(wú)需這種耗時(shí)而費(fèi)力的打結(jié)過(guò)程，對(duì)所有的外科醫(yī)生和患者都十分有利。”
這種自我錨定的縫合線是由Quill醫(yī)學(xué)公司主席Gregory Ruff醫(yī)學(xué)博士發(fā)明的，他在杜克大學(xué)醫(yī)學(xué)中心（Duke University Medical Center）外科工作了17年。Quill公司的產(chǎn)品針對(duì)普外科、整形外科和美容領(lǐng)域的不同需求。

Self-Anchoring Suture Needs No Knot
A new self-anchoring suture is designed for wound closure of dermal tissue. The suture has been cleared by the U.S. Food and Drug Administration (FDA).
The Barbed Polydioxanone suture is the first in a series of tissue repair devices being developed by Quill Medical, Inc. (Research Triangle Park, NC, USA), based on the company’s patented new suture technology. More than 40 obstetrician/gynecologists participated in a trial involving 195 patients to demonstrate the performance of the suture in closing a cesarian section incision. The doctors found the suture to be easier and faster to use than conventional suture material, the company advises.
“Surgeons worldwide use hundreds of millions of sutures each year to close wounds and repair tissue, all of which are secured with suture knots,” observed Matthew Megaro, president and CEO of Quill Medical. “The Quill self-anchoring suture eliminates painstaking and time-consuming knot-tying, a benefit to nearly all surgeons and patients.”
The self-anchoring suture was invented by Gregory Ruff, M.D., chairman of Quill Medical, who for 17 years was a member of the department of surgery at Duke University Medical Center. Quill’s products target diverse applications in general surgery, orthopedic, and aesthetics fields.